Sinclair Pharma PLC (SPH) Receives Consensus Rating of “Buy” from Analysts
Shares of Sinclair Pharma PLC (LON:SPH) have earned an average rating of “Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is GBX 54 ($0.70).
Several research analysts have weighed in on SPH shares. Peel Hunt reissued a “buy” rating and issued a GBX 68 ($0.88) price target on shares of Sinclair Pharma PLC in a report on Tuesday, March 21st. Stifel Nicolaus reaffirmed a “buy” rating and set a GBX 71 ($0.92) target price on shares of Sinclair Pharma PLC in a report on Tuesday, March 21st. N+1 Singer reaffirmed a “buy” rating and set a GBX 42 ($0.54) target price on shares of Sinclair Pharma PLC in a report on Tuesday, March 21st. Jefferies Group LLC reaffirmed a “buy” rating and set a GBX 55 ($0.71) target price on shares of Sinclair Pharma PLC in a report on Wednesday, March 22nd. Finally, Numis Securities Ltd reaffirmed a “hold” rating and set a GBX 35 ($0.45) target price on shares of Sinclair Pharma PLC in a report on Tuesday, April 4th.
Sinclair Pharma PLC (SPH) opened at 30.25 on Monday. The company’s 50-day moving average price is GBX 31.97 and its 200 day moving average price is GBX 32.38. Sinclair Pharma PLC has a 52 week low of GBX 26.00 and a 52 week high of GBX 36.35. The company’s market capitalization is GBX 151.91 million.
TRADEMARK VIOLATION NOTICE: “Sinclair Pharma PLC (SPH) Receives Consensus Rating of “Buy” from Analysts” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another site, it was illegally copied and republished in violation of US and international copyright and trademark law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/07/10/sinclair-pharma-plc-sph-receives-consensus-rating-of-buy-from-analysts.html.
Sinclair Pharma PLC Company Profile
Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.
Receive News & Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related companies with MarketBeat.com's FREE daily email newsletter.